David Beauvais

18PUBLICATIONS
59CO-AUTHORS
Transplantation immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Psychological methodology, design and analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 13, 2026
Alternative versus matched unrelated donor in adolescents and young adults transplanted for acute myeloid leukemia in first complete remission: A report from the SFGM-TC.

Aude-Marie Fourmont, David Beauvais, Marie Balsat

|Sep 15, 2025
Anti-CD19 CAR T-cell therapy for patients with Richter transformation: A LYSA study from the DESCAR-T registry.

Hedi Bensaber, Emmanuel Ferrant, Rémy Duléry

|Aug 21, 2025
Acute myeloid leukemia after CAR T-cell therapy: role of pre-existing clonal hematopoiesis and inflammation in leukemogenesis.

Paul Chauvet, Cynthia Saade, Julie Demaret

|Feb 27, 2025
Correction: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.

Gabrielle Meyers, Mehdi Hamadani, Michael Martens

|Aug 29, 2024
Efficacy and tolerance of brexucabtagene autoleucel in adults with R/R B-ALL: a GRAALL study from the DESCAR-T registry.

Florence Rabian, David Beauvais, Tony Marchand

|Mar 22, 2024
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Sara Villar, Sylvie Chevret, Xavier Poire

Pageof 3

Frequent Collaborators

4 joint publications

Patrice Chevallier

3 joint publications

Michaël Loschi

3 joint publications

Edouard Forcade

3 joint publications

Xavier Poiré